CytoSorbents Corporation (CTSO)

[biotech48]

CTSO decided not to go with the EAP, they are going for approval for Cardiac Surgery, not sepsis. They will go for sepsis approval when they have more revenue or when they have a partner to help pay. You lost your hiney of Spectral, so you know how that works. There is absolutely no worries about safety, you can rant on and mislead, but over 20,000 successful treatments. 20,000 successful treatments is a huge data lock. The FDA simply wants reliable, credible and valid large scale data for both efficacy and Safety, that is your one true statement. CTSO has shown the world safety, the efficacy is coming. That is exactly why newbies can buy CTSO at $5.70 per share now or wait for the data and pay $20.00 per share. ...You know this...but are baiting the susceptible Newbies. They should believe the adopting EU docs who have full approval and are increasing sales by new records each quarter.